Wang Lianjing相关文献与解析，生知库 | 链接生命科学的每一步

ATF6 activation promotes tumorigenesis and drug resistance in diffuse large B-cell lymphoma (DLBCL) by regulating the mTOR/S6K signaling pathway.

ATF6 激活通过调节 mTOR/S6K 信号通路促进弥漫性大 B 细胞淋巴瘤 (DLBCL) 的肿瘤发生和耐药性

期刊:Discover Oncology

影响因子:2.9

doi:10.1007/s12672-025-02264-1

Su Shuang, Wu Lili, Huang Chen, He Cuiying, Wang Lianjing, Li Weijing, Liu Wei, Liu Lihong

PIM1 kinase promotes EMT-associated osimertinib resistance via regulating GSK3β signaling pathway in EGFR-mutant non-small cell lung cancer

PIM1激酶通过调节EGFR突变非小细胞肺癌中的GSK3β信号通路促进EMT相关的奥希替尼耐药性

期刊:Cell Death & Disease

影响因子:8.1

doi:10.1038/s41419-024-07039-0

Jing Zhou #, Xinyue Wang #, Zhaona Li, Fan Wang, Lianjing Cao, Xiuqiong Chen, Dingzhi Huang, Richeng Jiang1

Deep learning model for predicting the survival of patients with primary gastrointestinal lymphoma based on the SEER database and a multicentre external validation cohort

基于SEER数据库和多中心外部验证队列的深度学习模型用于预测原发性胃肠道淋巴瘤患者的生存期

期刊:Journal of Cancer Research and Clinical Oncology

影响因子:2.8

doi:10.1007/s00432-023-05123-0

Wang, Feifan; Chen, Lu; Liu, Lihong; Jia, Yitao; Li, Wei; Wang, Lianjing; Zhi, Jie; Liu, Wei; Li, Weijing; Li, Zhongxin

淋巴瘤

发表日期：2023

文献求助收藏

The Treatment of Diffuse Large B-Cell Lymphoma (Triple Expression) Involving the Breast, Spleen, and Bone in a Male Patient with Viral Hepatitis B: A Rare Case Report

一例罕见病例报告：男性乙型肝炎患者合并乳腺、脾脏和骨骼弥漫性大B细胞淋巴瘤（三重表达）的治疗

期刊:Cancer Management and Research

影响因子:2.6

doi:10.2147/CMAR.S427217

Zhou, Weiling; Gao, Qian; Wang, Lianjing; Li, Weijing; He, Cuiying; Li, Yanting; Feng, Lei; Liu, Wei; Liu, Lihong; Wang, Yuan

Association Between Polymorphism in Diabetes Susceptibility Gene Insulin-Like Growth Factor 2mRNA-Binding Protein 2 and Risk of Diffuse Large B-Cell Lymphoma

糖尿病易感基因胰岛素样生长因子2 mRNA结合蛋白2多态性与弥漫性大B细胞淋巴瘤风险的关联

期刊:Clinical Medicine Insights-Oncology

影响因子:1.9

doi:10.1177/11795549231201128

Zhou, Weiling; Gao, Qian; He, Cuiying; Wang, Lianjing; Wang, Yuan; Feng, Lei; Li, Weijing; Liu, Wei; Ma, Ruijuan; Liu, Lihong

Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis

原发性乳腺淋巴瘤基因组突变图谱：新一代测序分析

期刊:Disease Markers

影响因子:

doi:10.1155/2022/6441139

Zhang, Wenqi; Huang, Chen; Liu, Jingjing; Wu, Lili; Zhang, Huichao; Wu, Xiaolin; Wang, Lianjing; Li, Weijing; Liu, Wei; Liu, Lihong

淋巴瘤

发表日期：2022

文献求助收藏

ATF6 and pS6K as prognostic biomarkers in newly diagnosed diffuse large B-cell lymphoma.

ATF6 和 pS6K 作为新诊断的弥漫性大 B 细胞淋巴瘤的预后生物标志物。

ATF6 activation promotes tumorigenesis and drug resistance in diffuse large B-cell lymphoma (DLBCL) by regulating the mTOR/S6K signaling pathway.

ATF6 激活通过调节 mTOR/S6K 信号通路促进弥漫性大 B 细胞淋巴瘤 (DLBCL) 的肿瘤发生和耐药性

PIM1 kinase promotes EMT-associated osimertinib resistance via regulating GSK3β signaling pathway in EGFR-mutant non-small cell lung cancer

PIM1激酶通过调节EGFR突变非小细胞肺癌中的GSK3β信号通路促进EMT相关的奥希替尼耐药性

Deep learning model for predicting the survival of patients with primary gastrointestinal lymphoma based on the SEER database and a multicentre external validation cohort

基于SEER数据库和多中心外部验证队列的深度学习模型用于预测原发性胃肠道淋巴瘤患者的生存期

The Treatment of Diffuse Large B-Cell Lymphoma (Triple Expression) Involving the Breast, Spleen, and Bone in a Male Patient with Viral Hepatitis B: A Rare Case Report

一例罕见病例报告：男性乙型肝炎患者合并乳腺、脾脏和骨骼弥漫性大B细胞淋巴瘤（三重表达）的治疗

Association Between Polymorphism in Diabetes Susceptibility Gene Insulin-Like Growth Factor 2mRNA-Binding Protein 2 and Risk of Diffuse Large B-Cell Lymphoma

糖尿病易感基因胰岛素样生长因子2 mRNA结合蛋白2多态性与弥漫性大B细胞淋巴瘤风险的关联

Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis

原发性乳腺淋巴瘤基因组突变图谱：新一代测序分析